Trevi Therapeutics, Inc. (TRVI)

Healthcare · Biotechnology · NASDAQ

Trevi Therapeutics, Inc. (TRVI) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.64B and a free-cash-flow yield of -1.7%.

Market cap	$2.64B
Trailing P/E	—
FCF yield	-1.7%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TRVI data on Nama Insights →